Research Grade Lesofavumab (DVV03805)

Description

Lesofavumab is a Recombinant monoclonal antibody to Influenza B virus hemagglutinin. Lesofavumab is a human monoclonal antibody that can be potentially used in the treatment of Influenza B infection. Genentech, a subsidiary of Roche, is developing lesofavumab (RG 6024), a monoclonal antibody, for the treatment of influenza B infections.

Catalog No.

DVV03805

Host species

Homo sapiens

Species reactivity

Influenza B virus

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Concentration

1 mg/ml

Purity

>95% by SDS-PAGE.

Clonality

Monoclonal

Isotype

IgG1, kappa

Applications

Research Grade Biosimilar

Target

HA/Hemagglutinin

Purification

Protein A or G purified from cell culture supernatant.

Endotoxin level

Please contact with the lab for this information.

Expression system

XtenCHO

Accession

P03461

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Alternative Names

RG6024, RG 6024, MHAB5553A, RG70026, RO7045557, CAS: 1807960-57-1, Influenza Virus (Flu)

Note

For research use only. Not suitable for clinical or therapeutic use.